Loading…
Loading…
Ilika plc (ILIKF) Q4 2026 Earnings Call Transcript
Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A) this week outlined continued commercial progress across its Stereax and Goliath solid-state battery businesses,...
Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A) this week outlined continued commercial progress across its Stereax and Goliath solid-state battery businesses, with chief executive Graeme Purdy highlighting the company's transition into revenue generation alongside several commercial catalysts expected over the next 12 to 18 months. Purdy, in an interview in the Proactive studio, said the most significant development for the Stereax business had been its move into commercial production, with Ilika now supplying commercial-grade electrodes to Cirtec for incorporation into the M300 medical device product, which is expected to reach the market later this year.
10am: Dow drops over 600 points at open Selling is dominating early stock trading on Wall Street, with the Dow Jones falling 611 points, or 1.16%, to...
Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A) flagged that it is now a revenue-generating business, with initial royalties from its miniature solid-state...
Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A) flagged that it is now a revenue-generating business, with initial royalties from its miniature solid-state batteries expected to flow in the 2027 financial year as it moves from development towards commercial production. In the battery developer's results for the year to April 2026, it noted that production of Stereax batteries has already begun with US manufacturing partner Cirtec Medical, supplying samples for customer testing and making initial deliveries.
Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A), the solid-state battery developer, said its retail offer was oversubscribed and raised around £500,000 through...
Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A), the AIM-listed developer of solid-state battery technology, received a broker endorsement after raising £4.5...
No recent filings indexed.